David F Chang
Overview
Explore the profile of David F Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1975
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang D, Li S, Court Pinto K, Nguyen T, Shah V, Morales E, et al.
bioRxiv
. 2025 Feb;
PMID: 39975037
Over four million people undergo radiation therapy annually in the United States. Among these, more than 90% experience varying degrees of radiation-induced skin injury. Despite the enormity of the problem,...
2.
So Many Injections, So Much Waste: Understanding the Environmental Impact of Intravitreal Injections
Grodsky J, Schehlein E, Chang D, Patel N, Scott N, Cole E, et al.
J Vitreoretin Dis
. 2024 Dec;
:24741264241308496.
PMID: 39726951
To understand the environmental burden associated with intravitreal injections (IVIs) and propose actionable solutions to mitigate this impact. An analysis of current IVI practices was conducted, focusing on packaging waste,...
3.
Ali M, Dun C, Chang D, Son H, Woreta F, Soiberman U, et al.
J Cataract Refract Surg
. 2024 Dec;
51(3):210-217.
PMID: 39696765
Purpose: To assess 5-year trends in the rate of immediate sequential bilateral cataract surgery (ISBCS) and surgeon characteristics associated with performing ISBCS. Setting: 100% Medicare Fee-For-Service beneficiaries from 2018 to...
4.
Winklmair N, Chang D, Findl O
Wien Med Wochenschr
. 2024 Nov;
PMID: 39535631
The healthcare sector, responsible for approximately 4-5% of global carbon dioxide equivalent (COeq) emissions, significantly impacts the environment due to its high energy consumption and waste generation. As a specialty,...
5.
Khan A, Mohamed E, Iqubal M, Tour J, McHugh E, Chang D, et al.
Int J Pharm
. 2024 Oct;
666:124834.
PMID: 39414186
The focus of current research work was to develop and validate size-exclusion chromatography method and develop and evaluate gel formulation of deferoxamine conjugated with PEGylated carbon nanoparticles (DEF-PEG-CNP) for topical...
6.
Kerrison C, Chang D, Dun C, Sabharwal J, Woreta F
J Cataract Refract Surg
. 2024 Oct;
51(2):91-97.
PMID: 39380186
Purpose: To assess postoperative endophthalmitis (POE) rates and risk factors after secondary intraocular lens (IOL) implantation for preoperative aphakia and IOL exchange combined with or without vitrectomy. Setting: Medicare fee-for-service...
7.
Keyser A, Chang D, Thiel C, Hovanesian J
J Cataract Refract Surg
. 2024 Jul;
50(12):1270-1274.
PMID: 38958944
Purpose: To analyze waste from intraocular lens (IOL) packaging across a variety of brands. Setting: Private clinical practice. Design: Prospective weight and composition analysis of all elements of unopened packages...
8.
Shukla A, Chang D, Dhanaseelan T, Vivekanandan V, Gubert J, Robin A, et al.
J Cataract Refract Surg
. 2024 Jun;
50(10):993-999.
PMID: 38915155
Purpose: To evaluate microbiological cultures of cataract surgical devices and products that were reused for multiple cases. Setting: Aravind Eye Hospital, Pondicherry, Tamil Nadu, India. Design: Prospective cohort study. Methods:...
9.
Awidi A, Chang D, Riaz K, Li X, LaBorwit S, Zebardast N, et al.
J Cataract Refract Surg
. 2024 Feb;
50(3):224-229.
PMID: 38381616
Purpose: To determine current prescribing patterns for topical or intraocular/periocular anti-inflammatory medications (AIMs) after routine cataract surgery. Setting: kera-net online members. Design: Cross-sectional survey. Methods: An online survey was distributed...
10.
Schehlein E, Hovanesian J, Shukla A, Talley Rostov A, Findl O, Chang D
J Cataract Refract Surg
. 2023 Dec;
50(3):197-200.
PMID: 38141003
Every ophthalmic surgical supply, including intraocular lenses (IOLs), IOL cartridges, and ophthalmic viscosurgical device syringes, is packaged with instructions for use (IFU). These pamphlets are printed in multiple languages and,...